Lou Ann Bruno-Murtha, D.O.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clostridium Infections | 2 | 2020 | 557 | 0.800 |
Why?
|
| Legionellosis | 1 | 2019 | 11 | 0.680 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 556 | 0.450 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 460 | 0.450 |
Why?
|
| Catheter-Related Infections | 1 | 2016 | 272 | 0.440 |
Why?
|
| Probiotics | 1 | 2016 | 377 | 0.420 |
Why?
|
| Communicable Diseases | 1 | 2020 | 879 | 0.390 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 782 | 0.360 |
Why?
|
| Cross Infection | 2 | 2018 | 1434 | 0.360 |
Why?
|
| Bacteremia | 1 | 2016 | 979 | 0.340 |
Why?
|
| Health Personnel | 7 | 2022 | 3309 | 0.330 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 4168 | 0.270 |
Why?
|
| Bell Palsy | 1 | 2006 | 39 | 0.260 |
Why?
|
| Oxazolidinones | 1 | 2006 | 97 | 0.260 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2010 | 585 | 0.240 |
Why?
|
| Acetamides | 1 | 2006 | 256 | 0.240 |
Why?
|
| Klebsiella Infections | 2 | 2019 | 147 | 0.230 |
Why?
|
| Societies | 1 | 2020 | 108 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 6070 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 393 | 0.170 |
Why?
|
| Liver Abscess | 1 | 2019 | 81 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 980 | 0.160 |
Why?
|
| Masks | 1 | 2020 | 209 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2021 | 361 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1403 | 0.140 |
Why?
|
| Urinalysis | 1 | 2018 | 368 | 0.130 |
Why?
|
| Community Health Services | 1 | 2021 | 653 | 0.130 |
Why?
|
| Hospitals | 2 | 2020 | 3930 | 0.130 |
Why?
|
| Lactobacillus | 1 | 2016 | 204 | 0.130 |
Why?
|
| Arthroplasty, Replacement | 1 | 2018 | 309 | 0.120 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 413 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 7380 | 0.120 |
Why?
|
| Boston | 3 | 2021 | 9274 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 2 | 2019 | 255 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
| Occupational Diseases | 1 | 2020 | 1484 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 12268 | 0.100 |
Why?
|
| Feces | 1 | 2018 | 1462 | 0.090 |
Why?
|
| Caliciviridae Infections | 1 | 2009 | 29 | 0.090 |
Why?
|
| Ships | 1 | 2009 | 53 | 0.080 |
Why?
|
| Norovirus | 1 | 2009 | 36 | 0.080 |
Why?
|
| Sanitation | 1 | 2009 | 86 | 0.080 |
Why?
|
| Disinfection | 1 | 2010 | 211 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2009 | 238 | 0.070 |
Why?
|
| Humans | 21 | 2022 | 759255 | 0.070 |
Why?
|
| Muscles | 1 | 1990 | 1582 | 0.060 |
Why?
|
| Massachusetts | 3 | 2021 | 8788 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 1990 | 1342 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5317 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3087 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3836 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3207 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2006 | 407 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2005 | 367 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 1990 | 2298 | 0.050 |
Why?
|
| Middle Aged | 8 | 2021 | 219653 | 0.050 |
Why?
|
| Ageusia | 1 | 2020 | 19 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2006 | 966 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2009 | 1758 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25860 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 130 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2005 | 1195 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2020 | 220 | 0.040 |
Why?
|
| Bacteriuria | 1 | 2018 | 104 | 0.040 |
Why?
|
| Male | 10 | 2021 | 358719 | 0.040 |
Why?
|
| Olfaction Disorders | 1 | 2020 | 224 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 393 | 0.040 |
Why?
|
| Haiti | 1 | 2019 | 551 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 938 | 0.040 |
Why?
|
| Body Temperature | 1 | 2020 | 777 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 1294 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2010 | 3731 | 0.030 |
Why?
|
| Drug Costs | 1 | 2005 | 1183 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2021 | 41247 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2020 | 1072 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2005 | 2283 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5194 | 0.030 |
Why?
|
| Bacteria | 1 | 2005 | 2188 | 0.030 |
Why?
|
| Adult | 8 | 2021 | 219390 | 0.030 |
Why?
|
| Urban Population | 1 | 2021 | 2015 | 0.030 |
Why?
|
| Bacillaceae Infections | 1 | 1992 | 8 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 1619 | 0.030 |
Why?
|
| Bacillus cereus | 1 | 1992 | 36 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3438 | 0.020 |
Why?
|
| Female | 6 | 2021 | 390240 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2005 | 8540 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3354 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2018 | 2256 | 0.020 |
Why?
|
| Aged | 3 | 2018 | 168617 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2010 | 210 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 14442 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 2010 | 285 | 0.020 |
Why?
|
| Endocarditis, Bacterial | 1 | 1992 | 445 | 0.020 |
Why?
|
| Risk Factors | 3 | 2021 | 74167 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 80121 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12152 | 0.020 |
Why?
|
| Necrosis | 1 | 1990 | 1613 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13309 | 0.020 |
Why?
|
| Travel | 1 | 2009 | 786 | 0.010 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 694 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 58483 | 0.010 |
Why?
|
| Communicable Disease Control | 1 | 2009 | 844 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 21336 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 1404 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8609 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20461 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58867 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 40109 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2010 | 54204 | 0.000 |
Why?
|
| United States | 1 | 2009 | 72237 | 0.000 |
Why?
|